MetLife Investment Management’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $274K | Sell |
88,766
-121
| -0.1% | -$374 | ﹤0.01% | 2011 |
|
|
2025
Q1 | $310K | Buy |
88,887
+7,235
| +9% | +$25.3K | ﹤0.01% | 1956 |
|
|
2024
Q4 | $267K | Sell |
81,652
-59
| -0.1% | -$193 | ﹤0.01% | 2148 |
|
|
2024
Q3 | $315K | Hold |
81,711
| – | – | ﹤0.01% | 2041 |
|
|
2024
Q2 | $252K | Buy |
81,711
+19,839
| +32% | +$61.3K | ﹤0.01% | 2101 |
|
|
2024
Q1 | $160K | Buy |
61,872
+2,891
| +5% | +$7.46K | ﹤0.01% | 2315 |
|
|
2023
Q4 | $147K | Hold |
58,981
| – | – | ﹤0.01% | 2404 |
|
|
2023
Q3 | $120K | Hold |
58,981
| – | – | ﹤0.01% | 2491 |
|
|
2023
Q2 | $136K | Hold |
58,981
| – | – | ﹤0.01% | 2505 |
|
|
2023
Q1 | $179K | Buy |
58,981
+14,846
| +34% | +$45K | ﹤0.01% | 2284 |
|
|
2022
Q4 | $103K | Sell |
44,135
-14,321
| -24% | -$33.4K | ﹤0.01% | 2584 |
|
|
2022
Q3 | $112K | Buy |
58,456
+23,312
| +66% | +$44.5K | ﹤0.01% | 2629 |
|
|
2022
Q2 | $95.2K | Sell |
35,144
-4,484
| -11% | -$12.2K | ﹤0.01% | 2730 |
|
|
2022
Q1 | $118K | Buy |
39,628
+29,648
| +297% | +$88.4K | ﹤0.01% | 2595 |
|
|
2021
Q4 | $38.8K | Sell |
9,980
-20,062
| -67% | -$78K | ﹤0.01% | 2471 |
|
|
2021
Q3 | $129K | Buy |
+30,042
| New | +$129K | ﹤0.01% | 2328 |
|
|
2018
Q4 | – | Sell |
-18,578
| Closed | -$176K | – | 2568 |
|
|
2018
Q3 | $176K | Buy |
+18,578
| New | +$176K | ﹤0.01% | 2157 |
|